Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastatic Breast Cancer
Evaluation Of Benefits of The Portable Scalp Cooling System (PSCS) in Metastatic Breast Cancer Patients on Taxane-Based Chemotherapy
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Withdrawn
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- City of Hope Medical Center
- Participants (registry)
- —
- Start
- December 2022 (planned)
- Primary completion
- November 2023
- Study completion
- November 2023
- Last registry update
- February 2023
- Countries
- —
Conditions studied: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Interventions: Cold Cap Therapy, Cold Cap, Paxman Scalp Cooling System, PSCS, Scalp Cooling, Scalp Cryotherapy, Scalp Hypothermia, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.